HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
- DOI
- 10.1038/s41467-021-27093-y
- Published
- 2021-11-18
- Container
- Nature Communications
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-021-27093-y,
title = {HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway},
author = {Alison E. Smith and Emanuela Ferraro and Anton Safonov and Cristina Bernado Morales and Enrique J. Arenas Lahuerta and Qing Li and Amanda Kulick and Dara Ross and David B. Solit and Elisa de Stanchina and Jorge Reis-Filho and Neal Rosen and Joaquín Arribas and Pedram Razavi and Sarat Chandarlapaty},
year = {2021},
journal = {Nature Communications},
doi = {10.1038/s41467-021-27093-y},
url = {https://doi.org/10.1038/s41467-021-27093-y}
}RIS
TY - JOUR TI - HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway AU - Alison E. Smith AU - Emanuela Ferraro AU - Anton Safonov AU - Cristina Bernado Morales AU - Enrique J. Arenas Lahuerta AU - Qing Li AU - Amanda Kulick AU - Dara Ross AU - David B. Solit AU - Elisa de Stanchina AU - Jorge Reis-Filho AU - Neal Rosen AU - Joaquín Arribas AU - Pedram Razavi AU - Sarat Chandarlapaty PY - 2021 JO - Nature Communications DO - 10.1038/s41467-021-27093-y UR - https://doi.org/10.1038/s41467-021-27093-y ER -
APA
Smith, A. E., Ferraro, E., Safonov, A., Morales, C. B., Lahuerta, E. J. A., Li, Q., Kulick, A., Ross, D., Solit, D. B., Stanchina, E. D., Reis-Filho, J., Rosen, N., Arribas, J., Razavi, P., & Chandarlapaty, S. (2021). HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway. Nature Communications. https://doi.org/10.1038/s41467-021-27093-y
Source records
- crossref · retrieved 2026-09-26T00:38:42.229Z